We are live on ! Find out more

Stocks Most Commonly
Held By Funds

Funds Holding Holding in Top 10 New Positions Closed Positions Increased Positions Reduced Positions Call Options Put Options
Name Funds
holding 		Growth Growth % Return since
30 Jun ‘23
QMAR icon
226
FT Vest Growth-100 Buffer ETF March
QMAR
$611M
59 +21 +55% 60.3%
AQST icon
227
Aquestive Therapeutics
AQST
$510M
54 +19 +54% 146%
OPRA icon
228
Opera Ltd
OPRA
$1.62B
74 +26 +54% 8.56%
HBIO icon
229
Harvard Bioscience
HBIO
$37.8M
100 +35 +54% 84.9%
IDMO icon
230
Invesco S&P International Developed Momentum ETF
IDMO
$4.19B
23 +8 +53% 79.2%
NSPR icon
231
InspireMD
NSPR
$22.5M
23 +8 +53% 80.9%
SDRL icon
232
Seadrill
SDRL
$2.9B
101 +35 +53% 12.2%
XMAR icon
233
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
$160M
58 +20 +53% 39%
NAMS icon
234
NewAmsterdam Pharma
NAMS
$2.46B
29 +10 +53% 73.4%
CZFS icon
235
Citizens Financial Services
CZFS
$381M
50 +17 +52% 8.38%
WEAV icon
236
Weave Communications
WEAV
$595M
103 +35 +51% 33.5%
GPOR icon
237
Gulfport Energy Corp
GPOR
$2.9B
146 +49 +51% 55.8%
GRSD icon
238
Grandstand Ltd
GRSD
$48.4M
78 +26 +50% 86.7%
QJUN icon
239
FT Vest Growth-100 Buffer ETF June
QJUN
$729M
63 +21 +50% 52.7%
IAUM icon
240
iShares Gold Trust Micro
IAUM
$6.61B
36 +12 +50% 117%
IMOM icon
241
Alpha Architect International Quantitative Momentum ETF
IMOM
$148M
24 +8 +50% 49.6%
HERD icon
242
Pacer Cash Cows Fund of Funds ETF
HERD
$104M
21 +7 +50% 49%
CURE icon
243
Direxion Daily Healthcare Bull 3X ETF
CURE
$186M
21 +7 +50% 48.7%
IMMX icon
244
Immix Biopharma
IMMX
$720M
18 +6 +50% 223%
RECS icon
245
Columbia Research Enhanced Core ETF
RECS
$6.19B
15 +5 +50% 77%
SPRE icon
246
SP Funds S&P Global REIT Sharia ETF
SPRE
$195M
15 +5 +50% 5.63%
QTJA icon
247
Innovator Growth Accelerated Plus ETF January
QTJA
$27.5M
12 +4 +50% 68.7%
IDVO icon
248
Amplify International Enhanced Dividend Income ETF
IDVO
$1.42B
12 +4 +50% 47.7%
ICCM icon
249
IceCure Medical
ICCM
$4.82M
12 +4 +50% 97%
SSPY icon
250
Syntax Stratified LargeCap ETF
SSPY
$130M
12 +4 +50% 46.2%
8 9
10
11 12